{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T07:35:39Z","timestamp":1775374539321,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-02485-4","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T08:42:50Z","timestamp":1746693770000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hsa-circVIM regulates breast cancer tumor progression and tamoxifen sensitivity by sponging miR-1294 in hormone receptor-positive breast cancer cells"],"prefix":"10.1007","volume":"16","author":[{"given":"Ying","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meini","family":"Cen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,8]]},"reference":[{"issue":"1","key":"2485_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348. https:\/\/doi.org\/10.3322\/caac.21763.","journal-title":"CA Cancer J Clin"},{"issue":"19","key":"2485_CR2","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.2174\/0929867322666150416095744","volume":"22","author":"D Ojo","year":"2015","unstructured":"Ojo D, Wei F, Liu Y, Wang E, Zhang H, Lin X, et al. Factors promoting tamoxifen resistance in breast cancer via stimulating breast cancer stem cell expansion. Curr Med Chem. 2015;22(19):2360\u201374. https:\/\/doi.org\/10.2174\/0929867322666150416095744.","journal-title":"Curr Med Chem"},{"key":"2485_CR3","doi-asserted-by":"publisher","unstructured":"Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005; 365(9472): 1687\u2013717. https:\/\/doi.org\/10.1016\/s0140-6736(05)66544-0.","DOI":"10.1016\/s0140-6736(05)66544-0"},{"issue":"9","key":"2485_CR4","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/nrc2713","volume":"9","author":"EA Musgrove","year":"2009","unstructured":"Musgrove EA, Sutherland RL. Biological determinants of endocrine resistance in breast cancer. Nat Rev Cancer. 2009;9(9):631\u201343. https:\/\/doi.org\/10.1038\/nrc2713.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"2485_CR5","doi-asserted-by":"publisher","first-page":"331","DOI":"10.6004\/jnccn.2024.0035","volume":"22","author":"WJ Gradishar","year":"2024","unstructured":"Gradishar WJ, Moran MS, Abraham J, Abramson V, Aft R, Agnese D, et al. Breast Cancer, Version 32024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024;22(5):331\u201357. https:\/\/doi.org\/10.6004\/jnccn.2024.0035.","journal-title":"J Natl Compr Canc Netw."},{"key":"2485_CR6","doi-asserted-by":"publisher","first-page":"1448687","DOI":"10.3389\/fonc.2024.1448687","volume":"14","author":"Y Gao","year":"2024","unstructured":"Gao Y, Yu Y, Zhang M, Yu W, Kang L. Mechanisms of endocrine resistance in hormone receptor-positive breast cancer. Front Oncol. 2024;14:1448687. https:\/\/doi.org\/10.3389\/fonc.2024.1448687.","journal-title":"Front Oncol"},{"key":"2485_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/s23063313","author":"B Liu","year":"2023","unstructured":"Liu B, Wang F, Chao J. Programmable Nanostructures Based on Framework-DNA for Applications in Biosensing. Sensors (Basel). 2023. https:\/\/doi.org\/10.3390\/s23063313.","journal-title":"Sensors (Basel)."},{"key":"2485_CR8","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.omtn.2021.01.002","volume":"23","author":"W Cui","year":"2021","unstructured":"Cui W, Dang Q, Chen C, Yuan W, Sun Z. Roles of circRNAs on tumor autophagy. Mol Ther Nucleic Acids. 2021;23:918\u201329. https:\/\/doi.org\/10.1016\/j.omtn.2021.01.002.","journal-title":"Mol Ther Nucleic Acids"},{"key":"2485_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.784996","volume":"12","author":"P Ruffo","year":"2021","unstructured":"Ruffo P, Strafella C, Cascella R, Caputo V, Conforti FL, And\u00f2 S, et al. Deregulation of ncRNA in neurodegenerative disease: focus on circRNA, lncRNA and miRNA in amyotrophic lateral sclerosis. Front Genet. 2021;12: 784996. https:\/\/doi.org\/10.3389\/fgene.2021.784996.","journal-title":"Front Genet"},{"key":"2485_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.canlet.2021.02.004","volume":"505","author":"L Chen","year":"2021","unstructured":"Chen L, Shan G. CircRNA in cancer: Fundamental mechanism and clinical potential. Cancer Lett. 2021;505:49\u201357. https:\/\/doi.org\/10.1016\/j.canlet.2021.02.004.","journal-title":"Cancer Lett"},{"key":"2485_CR11","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.cca.2021.09.013","volume":"523","author":"M Zhang","year":"2021","unstructured":"Zhang M, Bai X, Zeng X, Liu J, Liu F, Zhang Z. circRNA-miRNA-mRNA in breast cancer. Clin Chim Acta. 2021;523:120\u201330. https:\/\/doi.org\/10.1016\/j.cca.2021.09.013.","journal-title":"Clin Chim Acta"},{"issue":"1","key":"2485_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12943-020-01152-2","volume":"19","author":"G Liang","year":"2020","unstructured":"Liang G, Ling Y, Mehrpour M, Saw PE, Liu Z, Tan W, et al. Autophagy-associated circRNA circCDYL augments autophagy and promotes breast cancer progression. Mol Cancer. 2020;19(1):65. https:\/\/doi.org\/10.1186\/s12943-020-01152-2.","journal-title":"Mol Cancer"},{"issue":"14","key":"2485_CR13","doi-asserted-by":"publisher","first-page":"18978","DOI":"10.18632\/aging.203347","volume":"13","author":"W Zhang","year":"2021","unstructured":"Zhang W, Liu H, Jiang J, Yang Y, Wang W, Jia Z. CircRNA circFOXK2 facilitates oncogenesis in breast cancer via IGF2BP3\/miR-370 axis. Aging. 2021;13(14):18978\u201392. https:\/\/doi.org\/10.18632\/aging.203347.","journal-title":"Aging"},{"issue":"2","key":"2485_CR14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41419-020-2336-0","volume":"11","author":"L Cao","year":"2020","unstructured":"Cao L, Wang M, Dong Y, Xu B, Chen J, Ding Y, et al. Circular RNA circRNF20 promotes breast cancer tumorigenesis and Warburg effect through miR-487a\/HIF-1\u03b1\/HK2. Cell Death Dis. 2020;11(2):145. https:\/\/doi.org\/10.1038\/s41419-020-2336-0.","journal-title":"Cell Death Dis"},{"key":"2485_CR15","doi-asserted-by":"publisher","unstructured":"Yi J, Wang L, Hu GS, Zhang YY, Du J, Ding JC, et al. CircPVT1 promotes ER-positive breast tumorigenesis and drug resistance by targeting ESR1 and MAVS. Embo J. 2023; e112408. https:\/\/doi.org\/10.15252\/embj.2022112408.","DOI":"10.15252\/embj.2022112408"},{"key":"2485_CR16","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s12254-016-0268-2","volume":"9","author":"SP Gampenrieder","year":"2016","unstructured":"Gampenrieder SP, Rinnerthaler G, Greil R. CDK4\/6 inhibition in luminal breast cancer. Memo. 2016;9:76\u201381. https:\/\/doi.org\/10.1007\/s12254-016-0268-2.","journal-title":"Memo"},{"issue":"4","key":"2485_CR17","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.7150\/thno.45302","volume":"11","author":"L Wang","year":"2021","unstructured":"Wang L, Yi J, Lu LY, Zhang YY, Wang L, Hu GS, et al. Estrogen-induced circRNA, circPGR, functions as a ceRNA to promote estrogen receptor-positive breast cancer cell growth by regulating cell cycle-related genes. Theranostics. 2021;11(4):1732\u201352. https:\/\/doi.org\/10.7150\/thno.45302.","journal-title":"Theranostics"},{"issue":"3","key":"2485_CR18","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2217\/epi-2018-0147","volume":"11","author":"C Yuan","year":"2019","unstructured":"Yuan C, Zhou L, Zhang L, Yin K, Peng J, Sha R, et al. Identification and integrated analysis of key differentially expressed circular RNAs in ER-positive subtype breast cancer. Epigenomics. 2019;11(3):297\u2013321. https:\/\/doi.org\/10.2217\/epi-2018-0147.","journal-title":"Epigenomics"},{"issue":"4","key":"2485_CR19","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.1002\/jcp.27145","volume":"234","author":"YY Yi","year":"2019","unstructured":"Yi YY, Yi J, Zhu X, Zhang J, Zhou J, Tang X, et al. Circular RNA of vimentin expression as a valuable predictor for acute myeloid leukemia development and prognosis. J Cell Physiol. 2019;234(4):3711\u20139. https:\/\/doi.org\/10.1002\/jcp.27145.","journal-title":"J Cell Physiol"},{"issue":"5","key":"2485_CR20","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s10565-021-09613-0","volume":"38","author":"C Gao","year":"2022","unstructured":"Gao C, Xu YJ, Qi L, Bao YF, Zhang L, Zheng L. CircRNA VIM silence synergizes with sevoflurane to inhibit immune escape and multiple oncogenic activities of esophageal cancer by simultaneously regulating miR-124\/PD-L1 axis. Cell Biol Toxicol. 2022;38(5):825\u201345. https:\/\/doi.org\/10.1007\/s10565-021-09613-0.","journal-title":"Cell Biol Toxicol"},{"issue":"1","key":"2485_CR21","doi-asserted-by":"publisher","first-page":"7313","DOI":"10.1038\/s41598-017-07550-9","volume":"7","author":"S Gao","year":"2017","unstructured":"Gao S, Li X, Ding X, Jiang L, Yang Q. Huaier extract restrains the proliferative potential of endocrine-resistant breast cancer cells through increased ATM by suppressing miR-203. Sci Rep. 2017;7(1):7313. https:\/\/doi.org\/10.1038\/s41598-017-07550-9.","journal-title":"Sci Rep"},{"issue":"4","key":"2485_CR22","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","volume":"55","author":"SA Bustin","year":"2009","unstructured":"Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009;55(4):611\u201322. https:\/\/doi.org\/10.1373\/clinchem.2008.112797.","journal-title":"Clin Chem"},{"issue":"21","key":"2485_CR23","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1080\/15384101.2020.1824717","volume":"19","author":"Z Li","year":"2020","unstructured":"Li Z, Zheng J, Lin W, Weng J, Hong W, Zou J, et al. Circular RNA hsa_circ_0001785 inhibits the proliferation, migration and invasion of breast cancer cells in vitro and in vivo by sponging miR-942 to upregulate SOCS3. Cell Cycle. 2020;19(21):2811\u201325. https:\/\/doi.org\/10.1080\/15384101.2020.1824717.","journal-title":"Cell Cycle"},{"issue":"2","key":"2485_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41419-018-1287-1","volume":"10","author":"Z Liu","year":"2019","unstructured":"Liu Z, Zhou Y, Liang G, Ling Y, Tan W, Tan L, et al. Circular RNA hsa_circ_001783 regulates breast cancer progression via sponging miR-200c-3p. Cell Death Dis. 2019;10(2):55. https:\/\/doi.org\/10.1038\/s41419-018-1287-1.","journal-title":"Cell Death Dis"},{"issue":"3","key":"2485_CR25","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41571-021-00585-y","volume":"19","author":"LS Kristensen","year":"2022","unstructured":"Kristensen LS, Jakobsen T, Hager H, Kjems J. The emerging roles of circRNAs in cancer and oncology. Nat Rev Clin Oncol. 2022;19(3):188\u2013206. https:\/\/doi.org\/10.1038\/s41571-021-00585-y.","journal-title":"Nat Rev Clin Oncol"},{"key":"2485_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.600487","volume":"10","author":"L Gao","year":"2020","unstructured":"Gao L, Shen K, Yin N, Jiang M. Comprehensive transcriptomic analysis reveals dysregulated competing endogenous RNA network in endocrine resistant breast cancer cells. Front Oncol. 2020;10: 600487. https:\/\/doi.org\/10.3389\/fonc.2020.600487.","journal-title":"Front Oncol"},{"key":"2485_CR27","doi-asserted-by":"publisher","first-page":"1028851","DOI":"10.1155\/2022\/1028851","volume":"2022","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Tan D, Xie Y, Wu L, Wu S, Tang Y, et al. CircEPSTI1 promotes the proliferation of HER2-positive breast cancer cells via circEPSTI1\/miR-145\/ERBB3 Axis. J Oncol. 2022;2022:1028851. https:\/\/doi.org\/10.1155\/2022\/1028851.","journal-title":"J Oncol"},{"issue":"12","key":"2485_CR28","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/s41419-020-03276-1","volume":"11","author":"G Huang","year":"2020","unstructured":"Huang G, Liang M, Liu H, Huang J, Li P, Wang C, et al. CircRNA hsa_circRNA_104348 promotes hepatocellular carcinoma progression through modulating miR-187-3p\/RTKN2 axis and activating Wnt\/\u03b2-catenin pathway. Cell Death Dis. 2020;11(12):1065. https:\/\/doi.org\/10.1038\/s41419-020-03276-1.","journal-title":"Cell Death Dis"},{"issue":"3\u20134","key":"2485_CR29","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41417-020-00218-z","volume":"28","author":"W Zhang","year":"2021","unstructured":"Zhang W, Liu T, Li T, Zhao X. Hsa_circRNA_102002 facilitates metastasis of papillary thyroid cancer through regulating miR-488-3p\/HAS2 axis. Cancer Gene Ther. 2021;28(3\u20134):279\u201393. https:\/\/doi.org\/10.1038\/s41417-020-00218-z.","journal-title":"Cancer Gene Ther"},{"issue":"12","key":"2485_CR30","doi-asserted-by":"publisher","first-page":"6898","DOI":"10.1111\/jcmm.15346","volume":"24","author":"Y Liu","year":"2020","unstructured":"Liu Y, Chen S, Zong ZH, Guan X, Zhao Y. CircRNA WHSC1 targets the miR-646\/NPM1 pathway to promote the development of endometrial cancer. J Cell Mol Med. 2020;24(12):6898\u2013907. https:\/\/doi.org\/10.1111\/jcmm.15346.","journal-title":"J Cell Mol Med"},{"issue":"2","key":"2485_CR31","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.3892\/ol.2018.8967","volume":"16","author":"Z Wang","year":"2018","unstructured":"Wang Z, Yan J, Zou T, Gao H. MicroRNA-1294 inhibited oral squamous cell carcinoma growth by targeting c-Myc. Oncol Lett. 2018;16(2):2243\u201350. https:\/\/doi.org\/10.3892\/ol.2018.8967.","journal-title":"Oncol Lett"},{"issue":"24","key":"2485_CR32","doi-asserted-by":"publisher","first-page":"8582","DOI":"10.26355\/eurrev_201812_16621","volume":"22","author":"ZF Zhang","year":"2018","unstructured":"Zhang ZF, Li GR, Cao CN, Xu Q, Wang GD, Jiang XF. MicroRNA-1294 targets HOXA9 and has a tumor suppressive role in osteosarcoma. Eur Rev Med Pharmacol Sci. 2018;22(24):8582\u20138. https:\/\/doi.org\/10.26355\/eurrev_201812_16621.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"9","key":"2485_CR33","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.26355\/eurrev_201905_17797","volume":"23","author":"W Pan","year":"2019","unstructured":"Pan W, Pang LJ, Cai HL, Wu Y, Zhang W, Fang JC. MiR-1294 acts as a tumor suppressor in clear cell renal cell carcinoma through targeting HOXA6. Eur Rev Med Pharmacol Sci. 2019;23(9):3719\u201325. https:\/\/doi.org\/10.26355\/eurrev_201905_17797.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"10","key":"2485_CR34","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.bulcan.2022.02.017","volume":"109","author":"K Chen","year":"2022","unstructured":"Chen K, Xiao X, Xu Z. MiR-1294 inhibits the progression of breast cancer via regulating ERK signaling. Bull Cancer. 2022;109(10):999\u20131006. https:\/\/doi.org\/10.1016\/j.bulcan.2022.02.017.","journal-title":"Bull Cancer"},{"issue":"3","key":"2485_CR35","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/(sici)1098-2264(199607)16:3<170::Aid-gcc3>3.0.Co;2-w","volume":"16","author":"EM Berns","year":"1996","unstructured":"Berns EM, Klijn JG, Smid M, van Staveren IL, Look MP, van Putten WL, et al. TP53 and MYC gene alterations independently predict poor prognosis in breast cancer patients. Genes Chromosomes Cancer. 1996;16(3):170\u20139. https:\/\/doi.org\/10.1002\/(sici)1098-2264(199607)16:3%3c170::Aid-gcc3%3e3.0.Co;2-w.","journal-title":"Genes Chromosomes Cancer"},{"issue":"24","key":"2485_CR36","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.1111\/1759-7714.14703","volume":"13","author":"X Lin","year":"2022","unstructured":"Lin X, Lin X, Guo L, Wang Y, Zhang G. Distinct clinicopathological characteristics, genomic alteration and prognosis in breast cancer with concurrent TP53 mutation and MYC amplification. Thorac Cancer. 2022;13(24):3441\u201350. https:\/\/doi.org\/10.1111\/1759-7714.14703.","journal-title":"Thorac Cancer"},{"issue":"9","key":"2485_CR37","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1002\/ijc.34660","volume":"153","author":"ME Roche","year":"2023","unstructured":"Roche ME, Ko YH, Domingo-Vidal M, Lin Z, Whitaker-Menezes D, Birbe RC, et al. TP53 induced glycolysis and apoptosis regulator and monocarboxylate transporter 4 drive metabolic reprogramming with c-MYC and NFkB activation in breast cancer. Int J Cancer. 2023;153(9):1671\u201383. https:\/\/doi.org\/10.1002\/ijc.34660.","journal-title":"Int J Cancer"},{"key":"2485_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222312865","author":"V Sivaganesh","year":"2021","unstructured":"Sivaganesh V, Sivaganesh V, Scanlon C, Iskander A, Maher S, L\u00ea T, et al. Protein tyrosine phosphatases: mechanisms in cancer. Int J Mol Sci. 2021;22(23):12865. https:\/\/doi.org\/10.3390\/ijms222312865.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2485_CR39","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/jcp.27211","volume":"234","author":"T Venkatesh","year":"2019","unstructured":"Venkatesh T, Shetty A, Chakraborti S, Suresh PS. PTPH1 immunohistochemical expression and promoter methylation in breast cancer patients from India: A retrospective study. J Cell Physiol. 2019;234(2):1071\u20139. https:\/\/doi.org\/10.1002\/jcp.27211.","journal-title":"J Cell Physiol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02485-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-02485-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02485-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T08:42:51Z","timestamp":1746693771000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-02485-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,8]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2485"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-02485-4","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,8]]},"assertion":[{"value":"18 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by The Ethics Committee of The Affiliated Hospital of Youjiang Medical University for Nationalities and followed the principles outlined in the Declaration of Helsinki. In addition, informed consent has been obtained from the participants involved.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"692"}}